Valantine plans option-based sale; prior 25,484 shares sold (BBIO)
Rhea-AI Filing Summary
Hannah A Valantine reported a Rule 144 notice to sell Common Stock. The filing shows a planned sale tied to a 03/10/2026 stock option exercise and reports a prior sale of 25,484 shares on 02/27/2026 for $1,717,779.60.
The transaction is listed through Morgan Stanley Smith Barney LLC, with the security identified as Common and the market noted as NASDAQ. The filing is a notice of proposed resale under Rule 144 rather than a Form 3/4 insider trade report.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice for a sale via option exercise and a recent reported disposition.
The filing lists a planned sale associated with a 03/10/2026 stock option exercise and reports a prior disposition of 25,484 shares on 02/27/2026 for $1,717,779.60. This is a regulatory notice of resale activity under restricted‑securities resale rules.
Timing and cash‑flow mechanics are described as "Cash" and executed through Morgan Stanley Smith Barney LLC. Subsequent public filings would show actual execution details and any changes to the planned sale.